Cite

HARVARD Citation

    Wang, J. et al. (2019). Clinical outcomes of EGFR kinase domain duplication to targeted therapies in NSCLC. International journal of cancer. 144 (11), pp. 2677-2682. [Online]. 
  
Back to record